{"transactions":[{"id":1107922,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T20:00:07.000Z","date":"2025-06-15","kind":"grant","planned":false,"acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 15, 2025 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026."}],"balance_after":5450,"derivative":{"exercise_price":4.3,"expiration_date":"2035-06-14","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0001415889-25-017612","document":"form4-06172025_080603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588925017612/form4-06172025_080603.xml","form_type":"4"}},{"id":1107921,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T20:00:07.000Z","date":"2025-06-15","kind":"grant","planned":false,"acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,973 unvested RSUs."}],"balance_after":10374,"source":{"system":"sec-edgar","filing":"0001415889-25-017612","document":"form4-06172025_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588925017612/form4-06172025_080603.xml","form_type":"4"}},{"id":1482025,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:00:11.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":3150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 11, 2024 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024."}],"balance_after":3150,"derivative":{"exercise_price":6.18,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":3150},"source":{"system":"sec-edgar","filing":"0001415889-24-016571","document":"form4-06122024_080607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588924016571/form4-06122024_080607.xml","form_type":"4"}},{"id":1482024,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T20:00:11.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,603 unvested RSUs."}],"balance_after":7924,"source":{"system":"sec-edgar","filing":"0001415889-24-016571","document":"form4-06122024_080607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588924016571/form4-06122024_080607.xml","form_type":"4"}},{"id":1816308,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman Emeritus"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T16:23:28.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on the date of the Issuer's annual meeting of stockholders in 2024 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":3.26,"expiration_date":"2033-07-31","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-23-038054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000095017023038054/ownership.xml","form_type":"4"}},{"id":1845167,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:00:34.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on June 22, 2023 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023."}],"balance_after":2500,"derivative":{"exercise_price":14.56,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001415889-23-010289","document":"form4-06232023_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923010289/form4-06232023_080621.xml","form_type":"4"}},{"id":1845166,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:00:34.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":5046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter."}],"balance_after":5046,"derivative":{"exercise_price":14.56,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5046},"source":{"system":"sec-edgar","filing":"0001415889-23-010289","document":"form4-06232023_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923010289/form4-06232023_080621.xml","form_type":"4"}},{"id":1845165,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-23T20:00:34.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Grant of RSUs under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 6,524 unvested RSUs."}],"balance_after":6524,"source":{"system":"sec-edgar","filing":"0001415889-23-010289","document":"form4-06232023_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923010289/form4-06232023_080621.xml","form_type":"4"}},{"id":1845164,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-23T20:00:34.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":3784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,424 unvested RSUs."}],"balance_after":5424,"source":{"system":"sec-edgar","filing":"0001415889-23-010289","document":"form4-06232023_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923010289/form4-06232023_080621.xml","form_type":"4"}},{"id":1869717,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:00:44.000Z","date":"2023-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":800,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange, the reporting person received (i) in the case of the canceled options that were fully vested, a grant of 443 restricted stock units (the \"RSUs\") that vest over two years, with 50% of such RSUs vesting on May 31, 2024 and 50% of such RSUs vesting on May 31, 2025 and (ii) in the case of the canceled options that were unvested, a grant of 1,197 RSUs that vest 100% on May 31, 2025, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The cancelled option was granted on June 16, 2022 and provided for vesting as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001415889-23-009141","document":"form4-06022023_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923009141/form4-06022023_080636.xml","form_type":"4"}},{"id":1869716,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:00:44.000Z","date":"2023-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":840,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange, the reporting person received (i) in the case of the canceled options that were fully vested, a grant of 443 restricted stock units (the \"RSUs\") that vest over two years, with 50% of such RSUs vesting on May 31, 2024 and 50% of such RSUs vesting on May 31, 2025 and (ii) in the case of the canceled options that were unvested, a grant of 1,197 RSUs that vest 100% on May 31, 2025, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The cancelled option was granted on October 15, 2021 and provided for vesting with respect to 1/3rd of the shares underlying the option on October 15, 2022 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 15, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of shares and exercise price reflect a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022."}],"balance_after":0,"derivative":{"exercise_price":110.5,"expiration_date":"2031-10-14","underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001415889-23-009141","document":"form4-06022023_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923009141/form4-06022023_080636.xml","form_type":"4"}},{"id":1869715,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:00:44.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":1640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange, the reporting person received (i) in the case of the canceled options that were fully vested, a grant of 443 restricted stock units (the \"RSUs\") that vest over two years, with 50% of such RSUs vesting on May 31, 2024 and 50% of such RSUs vesting on May 31, 2025 and (ii) in the case of the canceled options that were unvested, a grant of 1,197 RSUs that vest 100% on May 31, 2025, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,640 unvested RSUs."}],"balance_after":1640,"source":{"system":"sec-edgar","filing":"0001415889-23-009141","document":"form4-06022023_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588923009141/form4-06022023_080636.xml","form_type":"4"}},{"id":2060348,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T17:16:16.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":2.7183,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-23-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000147450623000010/primary_doc.xml","form_type":"4"}},{"id":2228000,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T16:46:01.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022."}],"balance_after":40000,"derivative":{"exercise_price":0.36,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-22-006754","document":"form4-06172022_040632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588922006754/form4-06172022_040632.xml","form_type":"4"}},{"id":2524490,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-04T20:18:31.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on June 15, 2022, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":4.05,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-21-000161","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000147450621000161/primary_doc.xml","form_type":"4"}},{"id":2539285,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-19T16:08:42.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 15, 2021 and vests with respect to 1/3rd of the shares underlying the option on October 15, 2022 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 15, 2024."}],"balance_after":42000,"derivative":{"exercise_price":2.21,"expiration_date":"2031-10-14","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001415889-21-004907","document":"form4-10192021_011033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000141588921004907/form4-10192021_011033.xml","form_type":"4"}},{"id":3048703,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T16:25:54.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":5000,"price":6.73,"value":33650.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split, which is reflected in the amount shown in column 5."}],"balance_after":5578,"source":{"system":"sec-edgar","filing":"0001474506-20-000239","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000147450620000239/primary_doc.xml","form_type":"4"}},{"id":3103083,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T16:25:23.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal monthly installments over 12 months starting one month after the grant date (June 18, 2020), provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":3333,"derivative":{"exercise_price":6.7,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001267602-20-000097","document":"wf-form4_159285750598570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760220000097/wf-form4_159285750598570.xml","form_type":"4"}},{"id":3482402,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T16:26:21.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal monthly installments over 12 months starting one month after the grant date (June 19, 2019), provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.92,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001267602-19-000092","document":"wf-form4_156106236739443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760219000092/wf-form4_156106236739443.xml","form_type":"4"}},{"id":3672249,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T16:35:40.000Z","date":"2019-02-05","kind":"tax_withholding","acquired":false,"shares":21966,"price":0.9775,"value":21471.765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of Restricted Stock Units. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock unit award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c)."}],"balance_after":158676,"source":{"system":"sec-edgar","filing":"0001267602-19-000035","document":"wf-form4_154948892544724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760219000035/wf-form4_154948892544724.xml","form_type":"4"}},{"id":3672248,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T16:35:40.000Z","date":"2019-02-04","kind":"tax_withholding","acquired":false,"shares":21966,"price":0.94,"value":20648.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of Restricted Stock Units. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock unit award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c)."}],"balance_after":180642,"source":{"system":"sec-edgar","filing":"0001267602-19-000035","document":"wf-form4_154948892544724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760219000035/wf-form4_154948892544724.xml","form_type":"4"}},{"id":4070401,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-08T18:52:39.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":2494,"price":1.0455,"value":2607.477,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":202608,"source":{"system":"sec-edgar","filing":"0001267602-18-000039","document":"wf-form5_151813394501045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000039/wf-form5_151813394501045.xml","form_type":"5"}},{"id":4070400,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-08T18:52:39.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2453,"price":1.0625,"value":2606.3125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":200114,"source":{"system":"sec-edgar","filing":"0001267602-18-000039","document":"wf-form5_151813394501045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000039/wf-form5_151813394501045.xml","form_type":"5"}},{"id":4070399,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-08T18:52:39.000Z","date":"2017-02-15","kind":"gift","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":197661,"source":{"system":"sec-edgar","filing":"0001267602-18-000039","document":"wf-form5_151813394501045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000039/wf-form5_151813394501045.xml","form_type":"5"}},{"id":4070398,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-08T18:52:39.000Z","date":"2017-02-15","kind":"gift","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":198161,"source":{"system":"sec-edgar","filing":"0001267602-18-000039","document":"wf-form5_151813394501045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000039/wf-form5_151813394501045.xml","form_type":"5"}},{"id":4070397,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-08T18:52:39.000Z","date":"2017-02-15","kind":"gift","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":198661,"source":{"system":"sec-edgar","filing":"0001267602-18-000039","document":"wf-form5_151813394501045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000039/wf-form5_151813394501045.xml","form_type":"5"}},{"id":4089726,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-25T16:44:45.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":395000,"price":1.16,"value":458200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in forty-eight equal monthly installments beginning on January 22, 2018, provided that the Reporting Person remains continuously employed by the Issuer through each vesting period."}],"balance_after":395000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-01-21","underlying":"Common Stock","underlying_shares":395000},"source":{"system":"sec-edgar","filing":"0001267602-18-000037","document":"wf-form4_151691667182921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000037/wf-form4_151691667182921.xml","form_type":"4"}},{"id":4089725,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-25T16:44:45.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":124100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a restricted stock unit award (RSU). The RSU shall vest in two equal daily installments beginning on February 4, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."}],"balance_after":199161,"source":{"system":"sec-edgar","filing":"0001267602-18-000037","document":"wf-form4_151691667182921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000037/wf-form4_151691667182921.xml","form_type":"4"}},{"id":4094546,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-19T16:40:30.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":26450,"price":1.1802,"value":31216.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated August 11, 2017."}],"balance_after":75061,"source":{"system":"sec-edgar","filing":"0001267602-18-000027","document":"wf-form4_151639801630376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000027/wf-form4_151639801630376.xml","form_type":"4"}},{"id":4094545,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-19T16:40:30.000Z","date":"2018-01-18","kind":"sale","acquired":false,"shares":26450,"price":1.216,"value":32163.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated August 11, 2017."}],"balance_after":101511,"source":{"system":"sec-edgar","filing":"0001267602-18-000027","document":"wf-form4_151639801630376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000027/wf-form4_151639801630376.xml","form_type":"4"}},{"id":4096175,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-18T16:53:40.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":26450,"price":1.231,"value":32559.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated August 11, 2017."}],"balance_after":127961,"source":{"system":"sec-edgar","filing":"0001267602-18-000014","document":"wf-form4_151631240674770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000014/wf-form4_151631240674770.xml","form_type":"4"}},{"id":4096174,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-18T16:53:40.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":26450,"price":1.2376,"value":32734.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated August 11, 2017."}],"balance_after":154411,"source":{"system":"sec-edgar","filing":"0001267602-18-000014","document":"wf-form4_151631240674770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760218000014/wf-form4_151631240674770.xml","form_type":"4"}},{"id":4388681,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-03-13T16:56:30.000Z","date":"2017-03-10","kind":"sale","acquired":false,"shares":21172,"price":1.39,"value":29429.08,"ownership":{"direct":true},"balance_after":180861,"source":{"system":"sec-edgar","filing":"0001267602-17-000023","document":"wf-form4_148943857598840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000023/wf-form4_148943857598840.xml","form_type":"4"}},{"id":4453899,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-13T17:28:50.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":2455,"price":1.0625,"value":2608.4375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":98791,"source":{"system":"sec-edgar","filing":"0001267602-17-000014","document":"wf-form5_148702491299210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000014/wf-form5_148702491299210.xml","form_type":"5"}},{"id":4453898,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-13T17:28:50.000Z","date":"2016-04-29","kind":"grant","acquired":true,"shares":2103,"price":1.887,"value":3968.361,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":96336,"source":{"system":"sec-edgar","filing":"0001267602-17-000014","document":"wf-form5_148702491299210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000014/wf-form5_148702491299210.xml","form_type":"5"}},{"id":4453897,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-13T17:28:50.000Z","date":"2016-03-18","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":94233,"source":{"system":"sec-edgar","filing":"0001267602-17-000014","document":"wf-form5_148702491299210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000014/wf-form5_148702491299210.xml","form_type":"5"}},{"id":4453896,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-13T17:28:50.000Z","date":"2016-02-09","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":95233,"source":{"system":"sec-edgar","filing":"0001267602-17-000014","document":"wf-form5_148702491299210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000014/wf-form5_148702491299210.xml","form_type":"5"}},{"id":4453895,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-13T17:28:50.000Z","date":"2016-01-12","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96233,"source":{"system":"sec-edgar","filing":"0001267602-17-000014","document":"wf-form5_148702491299210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000014/wf-form5_148702491299210.xml","form_type":"5"}},{"id":4484141,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-23T17:00:59.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in forty-eight equal monthly installments beginning on January 20, 2017, provided that the Reporting Person remains continuously employed by the Issuer through each vesting period."}],"balance_after":425000,"derivative":{"exercise_price":1.18,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001267602-17-000011","document":"wf-form4_148520883958351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000011/wf-form4_148520883958351.xml","form_type":"4"}},{"id":4484140,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-01-23T17:00:59.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":105800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a restricted stock unit award (RSU). The RSU shall vest in four equal daily installments beginning on January 16, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."}],"balance_after":202033,"source":{"system":"sec-edgar","filing":"0001267602-17-000011","document":"wf-form4_148520883958351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760217000011/wf-form4_148520883958351.xml","form_type":"4"}},{"id":4580137,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-10-13T16:14:05.000Z","date":"2016-10-11","kind":"exercise","acquired":false,"shares":55147,"price":1.33,"value":73345.51,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Became exercisable with respect to one-quarter (1/4) of the shares of stock which are subject to this option on November 22, 2007 (the \"Initial Vesting Date\") and with respect to the remainder of the shares in equal increments quarterly over three (3) years beginning on the date three (3) months from the Initial Vesting Date."}],"balance_after":0,"derivative":{"exercise_price":1.33,"expiration_date":"2016-10-12","underlying":"Common Stock","underlying_shares":55147},"source":{"system":"sec-edgar","filing":"0001267602-16-000175","document":"wf-form4_147638963232428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760216000175/wf-form4_147638963232428.xml","form_type":"4"}},{"id":4580136,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2016-10-13T16:14:05.000Z","date":"2016-10-11","kind":"tax_withholding","acquired":false,"shares":48898,"price":1.5,"value":73347.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Myers irrevocably agreed to exercise these options through the \"net exercise\" method on August 17, 2016. Mr. Myers received 6,249 shares of common stock on a net exercise to purchase 55,147 shares of common stock. Mr. Myers forfeited 48,898 shares of common stock underlying the option in payment of the exercise price, using the closing stock price on October 11, 2016 of $1.50."}],"balance_after":96233,"source":{"system":"sec-edgar","filing":"0001267602-16-000175","document":"wf-form4_147638963232428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760216000175/wf-form4_147638963232428.xml","form_type":"4"}},{"id":4580135,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":78387,"kind":"person","name":"Myers C. Daniel","position":1,"cik":"0001489533","reported_name":"Myers C. Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2016-10-13T16:14:05.000Z","date":"2016-10-11","kind":"exercise","acquired":true,"shares":55147,"price":1.33,"value":73345.51,"ownership":{"direct":true},"balance_after":145131,"source":{"system":"sec-edgar","filing":"0001267602-16-000175","document":"wf-form4_147638963232428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489533/000126760216000175/wf-form4_147638963232428.xml","form_type":"4"}}]}